Panbela Therapeutics, Inc. (PBLA)

Panbela Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.26	2.58	1.29	11.87	9.02	2.45
Cash & Cash Equivalents	0.26	2.58	1.29	11.87	9.02	2.45
Cash Growth	-95.00%	100.62%	-89.17%	31.53%	268.40%	74.31%
Receivables	0.31	0.18	0.05	0.32	0.32	0.36
Other Current Assets	1.21	0.3	0.44	0.09	0.41	0.28
Total Current Assets	1.79	3.06	1.78	12.28	9.76	3.09
Other Long-Term Assets	8.74	8.74	3.2	0.59	0.06	0.05
Total Long-Term Assets	8.74	8.74	3.2	0.59	0.06	0.05
Total Assets	10.53	11.8	4.98	12.87	9.81	3.14
Accounts Payable	8.51	9.94	2.87	0.64	0.55	0.6
Current Debt	1	1	1.65	0	0	0.12
Other Current Liabilities	1.01	1.38	3.32	2.02	0.81	1.05
Total Current Liabilities	10.52	12.32	7.83	2.66	1.37	1.76
Long-Term Debt	3.19	4.19	5.19	0	0	0
Total Long-Term Liabilities	3.19	4.19	5.19	0	0	0
Total Liabilities	13.71	16.51	13.03	2.66	1.37	1.76
Total Debt	4.19	5.19	6.84	0	0	0.12
Debt Growth	-19.25%	-24.11%	-	-	-	-66.86%
Common Stock	0.01	0	0	0.01	0.01	0.01
Retained Earnings	-132.62	-125.5	-91.09	-56.16	-46.03	-41.26
Comprehensive Income	1.2	0.75	0.76	0.13	-0.38	0.31
Shareholders' Equity	-3.19	-4.71	-8.05	10.21	8.45	1.39
Total Liabilities and Equity	10.53	11.8	4.98	12.87	9.81	3.14
Net Cash / Debt	-3.93	-2.62	-5.56	11.87	9.02	2.33
Net Cash / Debt Growth	-	-	-	31.53%	286.71%	121.14%
Net Cash Per Share	-1.26	-24068.23	-6484.45	24323.78	28000.94	9822.62
Working Capital	-8.73	-9.26	-6.06	9.62	8.39	1.33
Book Value Per Share	-1.02	-43333.85	-9388.98	20931.53	26219.46	5831.26

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.